Renal Cancer
TREM-1 as a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma.
May 24, 2023
Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population.
May 23, 2023
Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma.
May 23, 2023
Triplet Strategies in Metastatic Clear Cell Renal Cell Carcinoma: A Worthy Option in the First-Line Setting?
May 22, 2023